Epstein Secrets

.62 1.71 NA NN 196.1 11311 51013 510.6 (11391 13.11 et» 0331 lab il laTii 13541 Ot01 22595 3.5 DU 23.7 41501 O.% I17.1) (1611 Laine 91.4711.1 11374.2 51.761.1 51./C0.9 6123 5200 5010 6431 4436 1151.2 I.101.1 1.175.5 1145 oto 104 5730 1959 149.7 55/6 (433.1 134

cash flows for its capital owners. Any future sale or transaction is expected to be based on the Company's future cash flow expectations. As such, the Income Approach was the primary methodology used in arriving at a value for the Company's equity. Please see Exhibits F and G for further details related to our an

.62 1.71 NA NN 196.1 11311 51013 510.6 (11391 13.11 et» 0331 lab il laTii 13541 Ot01 22595 3.5 DU 23.7 41501 O.% I17.1) (1611 Laine 91.4711.1 11374.2 51.761.1 51./C0.9 6123 5200 5010 6431 4436 1151.2 I.101.1 1.175.5 1145 oto 104 5730 1959 149.7 55/6 (433.1 134

cash flows for its capital owners. Any future sale or transaction is expected to be based on the Company's future cash flow expectations. As such, the Income Approach was the primary methodology used in arriving at a value for the Company's equity. Please see Exhibits F and G for further details related to our an

.62 1.71 NA NN 196.1 11311 51013 510.6 (11391 13.11 et» 0331 lab il laTii 13541 Ot01 22595 3.5 DU 23.7 41501 O.% I17.1) (1611 Laine 91.4711.1 11374.2 51.761.1 51./C0.9 6123 5200 5010 6431 4436 1151.2 I.101.1 1.175.5 1145 oto 104 5730 1959 149.7 55/6 (433.1 134

cash flows for its capital owners. Any future sale or transaction is expected to be based on the Company's future cash flow expectations. As such, the Income Approach was the primary methodology used in arriving at a value for the Company's equity. Please see Exhibits F and G for further details related to our an